Clinical Trials Browser

INDUSTRY × Neoplasms × Radiotherapy, Intensity-Modulated × Clear all

NCT02555644 2019-02-15

A Study of Prexasertib (LY2606368) With Chemotherapy and Radiation in Participants With Head and Neck Cancer

Phase 1 Completed

Head and Neck Neoplasms, Neoplasms